Walter, R. B., Gyurkocza, B., Storer, B. E., Godwin, C. D., Pagel, J. M., Buckley, S. A., . . . Sandmaier, B. M. (2014). Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation. Leukemia.
Chicago-стиль цитированияWalter, Roland B., et al. "Comparison of Minimal Residual Disease As Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation." Leukemia 2014.
MLA-цитированиеWalter, Roland B., et al. "Comparison of Minimal Residual Disease As Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation." Leukemia 2014.